Your browser doesn't support javascript.
loading
A new pancreatic adenocarcinoma-derived organoid model of acquired chemoresistance to FOLFIRINOX: First insight of the underlying mechanisms.
Hadj Bachir, Elsa; Poiraud, Charles; Paget, Sonia; Stoup, Nicolas; El Moghrabi, Soumaya; Duchêne, Belinda; Jouy, Nathalie; Bongiovanni, Antonino; Tardivel, Meryem; Weiswald, Louis-Bastien; Vandepeutte, Marie; Beugniez, César; Escande, Fabienne; Leteurtre, Emmanuelle; Poulain, Laurent; Lagadec, Chann; Pigny, Pascal; Jonckheere, Nicolas; Renaud, Florence; Truant, Stephanie; Van Seuningen, Isabelle; Vincent, Audrey.
Afiliação
  • Hadj Bachir E; CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Univ. Lille, Lille, France.
  • Poiraud C; CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Univ. Lille, Lille, France.
  • Paget S; Department of Digestive Surgery and Transplantation, CHU Lille, Lille, France.
  • Stoup N; CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Univ. Lille, Lille, France.
  • El Moghrabi S; CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Univ. Lille, Lille, France.
  • Duchêne B; CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Univ. Lille, Lille, France.
  • Jouy N; CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Univ. Lille, Lille, France.
  • Bongiovanni A; UMS 2014 - US 41 - PLBS - Plateformes Lilloises en Biologie & Santé, BioImaging Center Lille (BICeL), Univ. Lille, Lille, France.
  • Tardivel M; UMS 2014 - US 41 - PLBS - Plateformes Lilloises en Biologie & Santé, BioImaging Center Lille (BICeL), Univ. Lille, Lille, France.
  • Weiswald LB; UMS 2014 - US 41 - PLBS - Plateformes Lilloises en Biologie & Santé, BioImaging Center Lille (BICeL), Univ. Lille, Lille, France.
  • Vandepeutte M; UNICAEN, Inserm U1086 ANTICIPE "Interdisciplinary Research Unit for Cancer Prevention and Treatment", Normandie Univ, Caen, France.
  • Beugniez C; Cancer Centre F. Baclesse, UNICANCER, Caen, France.
  • Escande F; CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Univ. Lille, Lille, France.
  • Leteurtre E; CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Univ. Lille, Lille, France.
  • Poulain L; Department of Biochemistry and Molecular Biology, CHU Lille, Hormonology Metabolism Nutrition Oncology, Lille, France.
  • Lagadec C; CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Univ. Lille, Lille, France.
  • Pigny P; Department of Pathology, CHU Lille, Univ. Lille, Lille, France.
  • Jonckheere N; CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Univ. Lille, Lille, France.
  • Renaud F; UNICAEN, Inserm U1086 ANTICIPE "Interdisciplinary Research Unit for Cancer Prevention and Treatment", Normandie Univ, Caen, France.
  • Truant S; Cancer Centre F. Baclesse, UNICANCER, Caen, France.
  • Van Seuningen I; CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Univ. Lille, Lille, France.
  • Vincent A; CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Univ. Lille, Lille, France.
Biol Cell ; 114(1): 32-55, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34561874
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Biol Cell Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Biol Cell Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França